Summary
Mild hypoglycaemia was induced using an artificial pancreas in five normal subjects (from 5.00 ±0.15 to 2.83±0.15 mmol/l) by infusing 28 mU/m2 per min soluble insulin for 60 min. Six Type 1 (insulin-dependent) diabetic patients were stabilized for 14h using an artificial pancreas. They were then rendered hypoglycaemic (from 4.94±0.09 to 2.89±0.11 mmol/l) by infusing 28mU/m2 per min plus 16 ±3.8mU/min insulin for 60 min. Before the study, the diabetic patients were in optimal blood glucose control (mean blood glucose 6.72±0.11 mmol/l over the previous 14–20 days; HbA1 8.3±0.1%). During the insulin infusion test, blood glucose decrement was slower in the diabetic patients than in the control subjects. The blood glucose nadir was delayed in the diabetics until 75 min compared with 55 min in the control subjects. Blood glucose recovery rate in the diabetic subjects was severely impaired. In Type 1 diabetes, the counter-regulatory hormonal response to insulin induced hypoglycaemia is similar to that of non-diabetics, except for that of glucagon, the blunted response of which is not reversed by prolonged optimisation of blood glucose control. This impaired response of the A cell does not seem to be a consequence of insulin deficiency.
Article PDF
Similar content being viewed by others
References
Rizza RA, Cryer PE, Gerich JE (1979) Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. J Clin Invest 64: 62–71
Garber AJ, Cryer PE, Santiago JV, Haymond MW, Pagliara AS, Kipnis DM (1976) The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycaemia in man. J Clin Invest 58: 7–15
Gerich J, Cryer P, Rizza R (1980) Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone and cortisol. Metabolism 29: 1164–1175
Brodows RG, Pi-Sunyer FX, Campbell RG (1973) Neural control of counter-regulatory events during glucopenia in man. J Clin Invest 52: 1841–1844
Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH (1973) Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 182: 171–173
Benson JW Jr, Johnson DG, Palmer JP, Werner PL, Ensinck JW (1977) Glucagon and catecholamine secretion during hypoglycaemia in normal and diabetic man. J Clin Endocrinol Metab 44: 459–464
Maher TD, Taneberg RJ, Greenberg BZ, Hoffman JE, Doe RP, Goetz FC (1977) Lack of glucagon response to hypoglycaemia in diabetic autonomic neuropathy. Diabetes 26: 196–200
Campbell LV, Kraegen EW, Lazarus L (1977) Defective blood glucose counterregulation in diabetics in a selective form of autonomic neuropathy. Br Med J 2: 1527–1529
Saccà L, Sherwin R, Hendler R, Felig P (1979) Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. J Clin Invest 63: 849–857
Campbell LV, Kraegen EW, Meler H, Lazarus L (1979) Hormonal responses to insulin infusion in diabetes mellitus. Diabetologia 16: 359–364
Viberti GC, Keen H, Bloom SR (1980) Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in insulin-dependent diabetics. Metabolism 29: 873–879
Santiago JV, Clarke WL, Shah SD, Cryer PE (1980) Epinephrine, norepinephrine, glucagon and growth hormone release in association with physiological decrements in the plasma glucose concentration in normal and diabetic man. J Clin Endocrinol Metab 51: 877–883
Mackay JD, Page M McB, Cambridge J, Watkins PJ (1980) Diabetic autonomic neuropathy. Diabetologia 18: 471–478
Schlichtkrull J, Munck O, Jersild M (1965) The M-value, an index of blood sugar control in diabetics. Acta Med Scand 177: 95–102
Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19: 644–655
Faloona G, Unger R (1974) Glucagon. In: Jaffe B, Behrman H (eds) Methods of hormone radioimmunoassay. Academic Press, New York, pp 317–330
Peake G (1974) Growth hormone. In: Jaffe B, Behrman H (eds) Methods of hormone radioimmunoassay. Academic Press, New York, pp 103–121
Bolli G, Cartechini MG, Compagnucci P, Malvicini S, De Feo P, Angeletti G, Santeusanio F, Brunetti P (1979) Effect of metabolic control on urinary excretion and plasma levels of catecholamines in diabetics. Horm Metab Res 11: 493–497
Mattingly D (1964) A simple fluorimetric method for the estimation of 11-hydroxy-corticoids in human plasma. J Clin Pathol 15: 374–379
Yalow RS, Berson SA (1960) Immunoassay of endogenous plasma insulin in man. J Clin Invest 39: 1157–1175
Herbert V, Lav KS, Gottlieb GW, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25: 1375–1384
Compagnucci P, Cartechini MG, Bolli G, De Feo P, Santeusanio F, Brunetti P (1981) The importance of determining irreversibly glycosylated hemoglobin in diabetics. Diabetes 30: 607–612.
Beischer W, Keller L, Maas M, Schiefer E, Pfeiffer EF (1976) Human C Peptide, part I: radioimmunoassay. Klin Wochenschr 54: 709–716
Armitage P (1971) Statistical methods in medical research. Blackwell, Oxford, Edinburgh, pp 147–166, 394–407
Berson SA, Yalow RS, Bauman A, Rothchild MA, Newerly K (1956) Insulin-131I metabolism in human subjects. J Clin Invest 35: 170–190
Gibson RC, Stretcher GS, Williams TF (1966) Duration and magnitude of insulin effect in juvenile-onset diabetics. Clin Res 14: 63
Santeusanio F, Bolli G, Massi-Benedetti M, De Feo P, Angeletti G, Compagnucci P, Calabrese G, Brunetti P (1981) Counter-regulatory hormones during moderate, insulin-induced, blood glucose decrements in man. J Clin Endocrinol Metab 52: 477–482
De Feo P, Santeusanio F, Bolli G, Calabrese G, Compagnucci P, Cartechini MG, Angeletti G (1981) Counter-regulatory hormone response during prolonged but moderate hyperinsulinemia in normal man. Pan Med 23: in press
Ensinck JW, Kanter RA (1980) Glucagon responses to hypoglycemia in type 1 diabetic man after 24-hour glucoregulation by glucose-controlled insulin infusion. Diabetes Care 3: 285–289
Ohneda A, Watanabe K, Horigome K, Sakai T, Kai Y, Oikawa S (1978) Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus. J Clin Endocrinol Metab 46: 504–510
Unger RH (1971) Glucagon physiology and pathophysiology. N Engl J Med 285: 443–449
Shichiri M, Kawamori R, Abe H (1979) Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell. Diabetes 28: 272–275
Raskin P, Pietri A, Unger R (1979) Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps. Diabetes 28: 1033–1035
Kawamori R, Shichiri M, Kituchi M, Yamasaki Y, Abe H (1980) Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell. Diabetes 29: 762–765
Tamborlane WV, Sherwin RS, Koivisto V, Hendler R, Gessel M, Felig P (1979) Normalization of the growth hormone and catecholamine response to exercise in juvenile-onset diabetic subjects treated with a portable insulin-infusion pump. Diabetes 28: 785–788
Pickup JC, Keen H, Person JA, Alberti KGMM, Rwo AS (1979) Continuous subcutaneous insulin infusion: improved blood glucose and intermediary metabolites in diabetics. Lancet 1: 1255–1258
Palmer JP, Werner PL, Hollander P, Ensinck JW (1979) Evaluation of the control of glucagon secretion by the parasympathetic nervous system in man. Metabolism 28: 549–552
Walter RM, Dudl RJ, Palmer JP, Ensinck JW (1974) The effect of adrenergic blockade on the glucagon response to starvation and hypoglycemia in man. J Clin Invest 54: 1214–1220
Ensinck JW, Walter RM, Palmer JP, Brodows RG, Campbell RJ (1976) Glucagon responses to hypoglycaemia in adrenalectomized man. Metabolism 25: 227–232
Palmer JP, Henry DP, Benson JW, Johnson DG, Ensinck JW (1976) Glucagon response to hypoglycaemia in sympathectomized man. J Clin Invest 57: 522–525
Madsbad S, Hilsted J, Krarup T, Tronier B, Schwartz T (1981) The importance of autonomic neuropathy and of residual β-cell function for the pancreatic endocrine response to hypoglycemia in insulin-dependent diabetics. Diabetes 30 (Suppl 1): 44A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bolli, G., Calabrese, G., De Feo, P. et al. Lack of glucagon response in glucose counter-regulation in Type 1 (insulin-dependent) diabetics: Absence of recovery after prolonged optimal insulin therapy. Diabetologia 22, 100–105 (1982). https://doi.org/10.1007/BF00254837
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00254837